A detailed history of Achmea Investment Management B.V. transactions in United Therapeutics Corp stock. As of the latest transaction made, Achmea Investment Management B.V. holds 24,119 shares of UTHR stock, worth $8.77 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
24,119
Holding current value
$8.77 Million
% of portfolio
0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $7.5 Million - $8.77 Million
24,119 New
24,119 $8.64 Million
Q2 2023

Jul 24, 2023

SELL
$205.19 - $232.99 $19,082 - $21,668
-93 Reduced 1.89%
4,837 $1.07 Million
Q1 2023

May 04, 2023

BUY
$212.99 - $276.17 $1.05 Million - $1.36 Million
4,930 New
4,930 $1.1 Million
Q3 2020

Nov 02, 2020

SELL
$99.9 - $121.13 $87,112 - $105,625
-872 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$79.39 - $115.35 $69,228 - $100,585
872 New
872 $83,000
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $144,310 - $165,788
-1,928 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$76.06 - $120.81 $764,174 - $1.21 Million
-10,047 Reduced 83.9%
1,928 $150,000
Q4 2018

Feb 14, 2019

BUY
$101.4 - $128.73 $195,499 - $248,191
1,928 Added 19.19%
11,975 $1.3 Million
Q3 2018

Nov 06, 2018

SELL
$113.81 - $129.46 $225,685 - $256,719
-1,983 Reduced 16.48%
10,047 $1.28 Million
Q2 2018

Jul 27, 2018

SELL
$101.14 - $118.31 $527,141 - $616,631
-5,212 Reduced 30.23%
12,030 $1.36 Million
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $596,838 - $845,849
5,567 Added 47.68%
17,242 $1.93 Million
Q4 2017

Feb 12, 2018

SELL
$118.58 - $151.28 $537,523 - $685,752
-4,533 Reduced 27.97%
11,675 $1.73 Million
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $101,535 - $121,213
886 Added 5.78%
16,208 $1.9 Million
Q2 2017

Aug 29, 2017

BUY
N/A
15,322
15,322 $1.99 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.